Based on previous evidence, we hypothesized that OGT participates in the pathogenesis and process of high phosphate-induced VC in CKD settings, which may be involved in the regulation of the KEAP1/NRF2 axis. This evidence concerns the gene NFE2L2 and chronic kidney disease.